BBRRF (Blueberries Medical) Tariff Resilience Score: 4/10 (As of Jul. 05, 2026)


What is Blueberries Medical Tariff Resilience Score?

Blueberries Medical BBRRF Tariff Resilience Score is 4 as of Jul. 05, 2026. The stock has 2 warning signs investors should review. Among 1,028 Drug Manufacturers companies, Blueberries Medical ranks better than 79.77% on this metric.

Blueberries Medical has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Blueberries Medical has High exposure due to agricultural product exports. Dependent on international markets, with significant revenue from exports. Previous tariffs have impacted pricing. Limited mitigation strategies available, and industry is vulnerable to agricultural tariffs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Blueberries Medical might have Average Resilient.

Blueberries Medical  (OTCPK:BBRRF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Blueberries Medical Tariff Resilience Score Related Terms

BBRRF vs ZTS, UTHR: Tariff Resilience Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Blueberries Medical Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Blueberries Medical's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 4 mean?
Blueberries Medical (BBRRF) has a Tariff Resilience Score of 4 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Blueberries Medical ranks #208 out of 1028 companies in the Drug Manufacturers industry, placing it in the top 20.2%.
Is Blueberries Medical's Tariff Resilience Score too high?
Blueberries Medical's current Tariff Resilience Score is 4. Based on the distribution chart, Blueberries Medical ranks #208 out of 1028 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Blueberries Medical's Tariff Resilience Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #208 out of 1028 companies for Tariff Resilience Score. This places Blueberries Medical in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Blueberries Medical's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current Tariff Resilience Score is 4 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Blueberries Medical Business Description

Other Exchanges 1OA:GermanyBBM:Canada
Address 82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.